# Liposomal Bupivacaine Versus Interscalene Nerve Block

> **NCT03929146** · PHASE4 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 76 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Exparel
- **PROCEDURE:** Interscalene Nerve Block

## Key facts

- **NCT ID:** NCT03929146
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-05
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03929146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03929146, "Liposomal Bupivacaine Versus Interscalene Nerve Block". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03929146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*